Papillary Adenocarcinoma — Trials

Papillary Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

200 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 19
Ph III recruiting: 3
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06468696	Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients	unknown	N/A	170	Second Affiliated Hospital of Xi'an Jiaotong UniversityOTHER	1	Jun 21, 2024	clinicaltrials
NCT04354324	Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma	unknown	N/A	254	Zhujiang HospitalOTHER	1	Mar 15, 2024	clinicaltrials